PrimaGen Holding BV

PrimaGen Holding BV is an Academic Medical Center (AMC) spin-off company that develops molecular tests for diagnosing and monitoring certain types of cancer. Next to that, Primagen has several well-established programs for the development of molecular tests in the fields of mitochondrial toxicity, drug development toxicology screening, HIV monitoring and DFS paper technology.

PrimaGen Holding BV

Meibergdreef 59
1011 BA Amsterdam

info@primagen.com